EMA updates list of drugs subject to new labeling requirements

EMA published an updated Stribild elvitegravir/ cobicistat/emtricitabine/tenofovir from Gilead Sciences Inc. (NASDAQ:GILD), which the European Commission approved in May. EMA also removed two drugs fr...